1. Home
  2. CADE vs NUVL Comparison

CADE vs NUVL Comparison

Compare CADE & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cadence Bank

CADE

Cadence Bank

HOLD

Current Price

$42.05

Market Cap

8.0B

Sector

Finance

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$100.70

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADE
NUVL
Founded
1876
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CADE
NUVL
Price
$42.05
$100.70
Analyst Decision
Hold
Strong Buy
Analyst Count
11
15
Target Price
$41.00
$135.00
AVG Volume (30 Days)
2.8M
570.1K
Earning Date
01-22-2026
02-26-2026
Dividend Yield
2.55%
N/A
EPS Growth
2.17
N/A
EPS
2.83
N/A
Revenue
$1,859,476,000.00
N/A
Revenue This Year
$19.17
N/A
Revenue Next Year
$5.42
N/A
P/E Ratio
$15.25
N/A
Revenue Growth
8.00
N/A
52 Week Low
$25.22
$55.54
52 Week High
$46.74
$113.02

Technical Indicators

Market Signals
Indicator
CADE
NUVL
Relative Strength Index (RSI) 41.93 45.28
Support Level $42.44 $105.05
Resistance Level $43.40 $113.02
Average True Range (ATR) 1.20 5.03
MACD -0.39 -0.10
Stochastic Oscillator 6.80 24.60

Price Performance

Historical Comparison
CADE
NUVL

About CADE Cadence Bank

Cadence Bank is a bank based in the United States. The operating segments are Corporate Banking segment focuses on C&I, business banking, and commercial real estate lending to clients in the geographic footprint, Community Banking segment provides a broad range of banking services through the branch network to serve the needs of community businesses and individual consumers in the geographic footprint, Mortgage segment includes mortgage banking activities of originating mortgage loans, selling mortgage loans in the secondary market and servicing the mortgage loans, Banking Services segment offers individuals, businesses, governmental institutions, and non-profit entities a widerange of solutions to help protect, grow, and transfer wealth, General Corporate and Other segment.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: